February 27, 2025 12:10 PM ESTUpdated March 7, 11:50 AM

OpenAI meets cancer care

Lydia Ramsey Pflanzer

Deputy Editor

Most healthcare organizations have been using AI for decidedly unglamorous tasks like documentation and billing. Now we’re starting to see how it could be used …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

OpenAI meets cancer care

Lydia Ramsey Pflanzer

Deputy Editor

Sign up to read this article for free.

Executive Director, Marketing

Celldex Therapeutics

Hampton, NJ, USA

Marks’ exit at FDA rattles an already teetering biotech industry

Lilly's heart disease drug could be dosed as little as once a year, study shows

Inspirna, which was preparing for a Phase 3 cancer trial, has folded

Alphabet’s Isomorphic Labs raises $600M in biotech’s largest round of 2025

What’s next after Marks? At FDA, questions over more top exits and future vision for drug agency

Endpoints webinar: Inside the “One Lonza” strategy: Re-engineering the future of CDMO

Ope­nAI meets can­cer care

Deputy Editor

Sign up to read this article for free.

Celldex Therapeutics

Hampton, NJ, USA

OpenAI meets cancer care